Clinical Trials in Brazil / NCT07080645
Starting soon Not applicable

BIOSILITACE AS A DESENSITIZING AGENTIN HMI

NCT07080645 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2025-07-30
Last updated
2025-07-23

Condition(s) studied

Sensitive DentinHypomineralization Molar IncisorPain

Investigational drug(s) / intervention(s)

Pain Relievingtopical application

Pain Relieving: aim to relieve tooth pain with HMI Biosilicate

topical application: the operator will apply a solution to all the free surfaces of the selected teeth using a microapplicator. The solution will either be 10% Biosilicate® solution, fluoride varnish (Duraphat®), or distilled water . All products will be removed from their original containers and placed in identical 10ml plastic bottles, white and standardized. The different products will be applied equally for 15 seconds according to the application protocol.

Study summary

Molar-Incisor Hypomineralization (MIH) is a qualitative enamel defect caused by systemic hypomineralization that affects one to four first permanent molars, and may or may not involve incisors. The clinical repercussions associated with MIH can be characterized by: painful hypersensitivity, post-eruptive fractures, rapid progression of caries lesions in newly erupted first permanent molars, difficulty in achieving effective anesthesia, aesthetic impairments, and patient fear and anxiety. To date, there is no consensus on the best treatment for sensitivity in teeth with MIH, thus managing sensitivity in these teeth remains a significant challenge. The aim of this study is to evaluate the effectiveness of a 10% Biosilicate® solution as a desensitizing agent in MIH teeth in children, compared to Fluoride varnish (Duraphat® Colgate, Brazil). Children aged 6 to 12 years will be selected for this study, with a total of 63 participants diagnosed with MIH, and a sensitivity score ≥2 on the SCASS scale. The children will be randomly divided into two groups (n=21): GI: Duraphat®, GII: Biosilicate®. Interventions will be performed once a week for 4 consecutive weeks, followed by 8 weeks of follow-up. The results will be subjected to statistical tests with a 95% confidence level (α = 0.05).

Eligibility

Sex
ALL
Min age
6 Years
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria: * Children of both sexes, aged between 6 and 12 years. * Children who have at least one first permanent molar with Molar-Incisor Hypomineralization, showing distinct white or cream opacity (score 21), yellowish or brown opacity (score 22), and/or post-eruptive enamel fracture (score 3), and presence of painful sensitivity when stimulated, with a score of 2 or 3 as evaluated using the SCASS scale. * Children without systemic and/or cognitive impairments. Exclusion Criteria: * Previous use of desensitizing therapy in the last 6 months; * Use of analgesic and anti-inflammatory medications during the previous 3 days; * Use of orthodontic appliances; * Teeth with extensive restorative procedures, such as stainless steel crowns, which prevent the assessment of painful sensitivity; * Teeth with amelogenesis imperfecta or dentinogenesis imperfecta; * Children with systemic and/or cognitive impairments.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Faculdade de Odontologia de Ribeirão Preto FORP USP Ribeirão Preto São Paulo
Faculdade de Odontologia de Ribeirão Preto FORP USP Ribeirão Preto São Paulo

More University of Sao Paulo trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07080645 on ClinicalTrials.gov ↗ ← All trials in Brazil